Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Liver Resection Versus Embolization for Recurrent Hepatocellular Carcinoma.

Midorikawa Y, Takayama T, Moriguchi M, Yagi R, Yamagishi S, Nakayama H, Aramaki O, Yamazaki S, Tsuji S, Higaki T.

World J Surg. 2019 Oct 11. doi: 10.1007/s00268-019-05225-2. [Epub ahead of print]

PMID:
31605170
2.

The efficacy of acute normovolemic hemodilution for preventing perioperative allogeneic blood transfusion in gynecological cancer patients.

Saito J, Masui K, Noguchi S, Nakai K, Tamai Y, Midorikawa Y, Kinoshita H, Mikami N, Kitayama M, Hashimoto H, Hirota K.

J Clin Anesth. 2019 Aug 20;60:42-43. doi: 10.1016/j.jclinane.2019.08.025. [Epub ahead of print] No abstract available.

PMID:
31442857
3.

Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma.

Midorikawa Y, Takayama T, Nakayama H, Higaki T, Moriguchi M, Moriya K, Kanda T, Matsuoka S, Moriyama M.

BMC Gastroenterol. 2019 Aug 19;19(1):147. doi: 10.1186/s12876-019-1069-y.

4.

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection.

Song P, Midorikawa Y, Nakayama H, Higaki T, Moriguchi M, Aramaki O, Yamazaki S, Aoki M, Teramoto K, Takayama T.

Cancer Med. 2019 Oct;8(13):5862-5871. doi: 10.1002/cam4.2495. Epub 2019 Aug 13.

5.

Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.

Tatsuno K, Midorikawa Y, Takayama T, Yamamoto S, Nagae G, Moriyama M, Nakagawa H, Koike K, Moriya K, Aburatani H.

Clin Cancer Res. 2019 Oct 15;25(20):6217-6227. doi: 10.1158/1078-0432.CCR-18-4041. Epub 2019 Jul 18.

PMID:
31320595
6.

Conservative treatment for stable low-energy thoracolumbar vertebral fractures in nonfused segments among elderly patients with diffuse idiopathic skeletal hyperostosis: A matched case-control study.

Okano I, Tachibana T, Nishi M, Midorikawa Y, Hoshino Y, Sawada T, Kudo Y, Toyone T, Inagaki K.

Medicine (Baltimore). 2019 Jun;98(24):e16032. doi: 10.1097/MD.0000000000016032.

7.

Algorithm for Resecting Hepatocellular Carcinoma in the Caudate Lobe.

Takayama T, Midorikawa Y, Higaki T, Nakayama H, Moriguchi M, Aramaki O, Yamazaki S, Aoki M, Kogure K, Makuuchi M.

Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003384. [Epub ahead of print]

PMID:
31188213
8.

Prediction of esophageal varices by liver and spleen MR elastography.

Abe H, Midorikawa Y, Matsumoto N, Moriyama M, Shibutani K, Okada M, Udagawa S, Tsuji S, Takayama T.

Eur Radiol. 2019 Apr 30. doi: 10.1007/s00330-019-06230-8. [Epub ahead of print]

PMID:
31041563
9.

Recurrent femoral shaft fractures in a child with gnathodiaphyseal dysplasia: a case report.

Kuroda T, Okano I, Sawada T, Okamoto S, Midorikawa Y, Tachibana T, Yagi T, Inagaki K.

BMC Musculoskelet Disord. 2019 Feb 23;20(1):92. doi: 10.1186/s12891-019-2464-9.

10.

Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy.

Yamagishi S, Midorikawa Y, Nakayama H, Higaki T, Moriguchi M, Aramaki O, Yamazaki S, Tsuji S, Takayama T.

Hepatol Res. 2019 Apr;49(4):432-440. doi: 10.1111/hepr.13293. Epub 2019 Jan 2.

PMID:
30497106
11.

Usefulness of Continuous Renal Replacement Therapy During an Intra-Aortic Balloon Occlusion in Patients With Ruptured Abdominal Aortic Aneurysms.

Saito J, Tokita T, Takashima R, Kawaguchi J, Midorikawa Y, Noguchi S, Hahisba E, Hirota K.

J Cardiothorac Vasc Anesth. 2019 Aug;33(8):2237-2240. doi: 10.1053/j.jvca.2018.10.010. Epub 2018 Oct 13. No abstract available.

PMID:
30401597
12.

Risk factors for spinal cord injury progression after anterior fusion for cervical spine trauma: a retrospective case-control study.

Okano I, Midorikawa Y, Midorikawa N, Hoshino Y, Sawada T, Toyone T, Inagaki K.

Spinal Cord Ser Cases. 2018 Oct 5;4:90. doi: 10.1038/s41394-018-0123-2. eCollection 2018.

13.

Clinical application of magnetic resonance elastography in chronic liver disease.

Abe H, Midorikawa Y, Okada M, Takayama T.

Hepatol Res. 2018 Sep;48(10):780-787. doi: 10.1111/hepr.13231. Epub 2018 Aug 15. Review.

PMID:
30014566
14.

General Anesthetic Management for Emergency Cesarean Section and Postpartum Hemorrhage in a Woman With Fontan Circulation.

Saito J, Noguchi S, Nakai K, Midorikawa Y, Kimura F, Hirota K.

J Cardiothorac Vasc Anesth. 2019 Mar;33(3):791-795. doi: 10.1053/j.jvca.2018.05.012. Epub 2018 May 16. No abstract available.

PMID:
29935806
15.

Penetrating Anorectal Injury Caused by a Wild Boar Attack: A Case Report.

Okano I, Midorikawa Y, Kushima N, Watanabe Y, Sugiyama T, Mitachi K, Shinohara K, Sawada T, Inagaki K.

Wilderness Environ Med. 2018 Sep;29(3):375-379. doi: 10.1016/j.wem.2018.02.007. Epub 2018 May 3.

PMID:
29731409
16.

[Home Medical Care Promotion for Multidisciplinary Cooperation].

Midorikawa Y, Tamotsu K, Tsukita S, Kimura M, Yamauchi T.

Gan To Kagaku Ryoho. 2018 Mar;45(Suppl 1):58-60. Japanese.

PMID:
29650876
17.

Arterial infusion of cisplatin plus S-1 against unresectable intrahepatic cholangiocarcinoma.

Higaki T, Aramaki O, Moriguchi M, Nakayama H, Midorikawa Y, Takayama T.

Biosci Trends. 2018;12(1):73-78. doi: 10.5582/bst.2017.01320.

18.

Neither ischemic parenchymal volume nor severe grade complication correlate transient high transaminase elevation after liver resection.

Higaki T, Yamazaki S, Mitsuka Y, Aoki M, Yoshida N, Midorikawa Y, Nakayama H, Takayama T.

Biosci Trends. 2018;12(1):68-72. doi: 10.5582/bst.2018.01004.

19.

Ventral approach for resecting hepatocellular carcinoma in the caval portion of the caudate lobe.

Higaki T, Takayama T, Midorikawa Y.

Surgery. 2018 Jun;163(6):1245-1249. doi: 10.1016/j.surg.2018.01.002. Epub 2018 Feb 21.

PMID:
29475614
20.

Liver resection for recurrent hepatocellular carcinoma to improve survivability: a proposal of indication criteria.

Yagi R, Midorikawa Y, Moriguchi M, Nakayama H, Aramaki O, Yamazaki S, Higaki T, Takayama T.

Surgery. 2018 Jun;163(6):1250-1256. doi: 10.1016/j.surg.2017.12.022. Epub 2018 Feb 14.

PMID:
29452700
21.

Liver resection of hepatocellular carcinoma in patients with portal hypertension and multiple tumors.

Ohkubo T, Midorikawa Y, Nakayama H, Moriguchi M, Aramaki O, Yamazaki S, Higaki T, Takayama T.

Hepatol Res. 2018 May;48(6):433-441. doi: 10.1111/hepr.13047. Epub 2018 Jan 19.

PMID:
29277961
22.

A prediction model for the grade of liver fibrosis using magnetic resonance elastography.

Mitsuka Y, Midorikawa Y, Abe H, Matsumoto N, Moriyama M, Haradome H, Sugitani M, Tsuji S, Takayama T.

BMC Gastroenterol. 2017 Nov 28;17(1):133. doi: 10.1186/s12876-017-0700-z.

23.

Cell division cycle 34 is highly expressed in hepatitis C virus-positive hepatocellular carcinoma with favorable phenotypes.

Takagi K, Takayama T, Midorikawa Y, Hasegawa H, Ochiai T, Moriguchi M, Higaki T, Soma M, Nagase H, Fujiwara K.

Biomed Rep. 2017 Jul;7(1):41-46. doi: 10.3892/br.2017.912. Epub 2017 May 18.

24.

Complete Genome Sequence of the Lytic Giant Bacteriophage pT24 Infecting Tenacibaculum spp., Isolated from a Shrimp Culture Pond.

Khoa HV, Midorikawa Y, Uchino T, Nakai T, Kato G, Kondo H, Hirono I, Labaiden M, Direkbusarakom S, Sano M.

Genome Announc. 2017 Jul 6;5(27). pii: e00081-17. doi: 10.1128/genomeA.00081-17.

25.

Clinical correspondence to hepatocellular carcinoma-related lesions with atypical radiological pattern.

Higaki T, Midorikawa Y, Nakashima Y, Nakayama H, Matsuoka S, Moriyama M, Sugitani M, Takayama T.

Biosci Trends. 2017 Jul 24;11(3):340-345. doi: 10.5582/bst.2017.01110. Epub 2017 Jun 18.

27.

Predicting postoperative outcomes of liver resection by magnetic resonance elastography.

Abe H, Midorikawa Y, Mitsuka Y, Aramaki O, Higaki T, Matsumoto N, Moriyama M, Haradome H, Abe O, Sugitani M, Tsuji S, Takayama T.

Surgery. 2017 Aug;162(2):248-255. doi: 10.1016/j.surg.2017.02.014. Epub 2017 Apr 13.

PMID:
28411865
28.

A new orthodontic force system for moment control utilizing the flexibility of common wires: Evaluation of the effect of contractile force and hook length.

Lai WJ, Midorikawa Y, Kanno Z, Takemura H, Suga K, Soga K, Ono T, Uo M.

J Formos Med Assoc. 2018 Jan;117(1):71-79. doi: 10.1016/j.jfma.2017.03.002. Epub 2017 Apr 10.

29.

Six-axis orthodontic force and moment sensing system for dentist technique training.

Midorikawa Y, Takemura H, Mizoguchi H, Soga K, Kamimura M, Suga K, Wei-Jen Lai, Kanno Z, Uo M.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:2206-2209. doi: 10.1109/EMBC.2016.7591167.

PMID:
28268769
30.

Diabetes mellitus not an unfavorable factor on the prognosis of hepatitis C virus-related hepatocellular carcinoma.

Yoshida N, Midorikawa Y, Higaki T, Nakayama H, Tsuji S, Matsuoka S, Ishihara H, Moriyama M, Takayama T.

Hepatol Res. 2018 Jan;48(1):28-35. doi: 10.1111/hepr.12888. Epub 2017 Apr 1.

PMID:
28258663
31.

Randomized clinical trial comparing two vessel-sealing devices with crush clamping during liver transection.

Ichida A, Hasegawa K, Takayama T, Kudo H, Sakamoto Y, Yamazaki S, Midorikawa Y, Higaki T, Matsuyama Y, Kokudo N.

Br J Surg. 2016 Dec;103(13):1795-1803. doi: 10.1002/bjs.10297. Epub 2016 Sep 29.

PMID:
27682642
32.

Development and modification of a device for three-dimensional measurement of orthodontic force system: The V-bend system re-visited.

Lai W, Midorikawa Y, Kanno Z, Takemura H, Suga K, Soga K, Ono T, Uo M.

Dent Mater J. 2016 Dec 1;35(6):908-917. Epub 2016 Sep 29.

33.

Early hepatocellular carcinoma as a signaling lesion for subsequent malignancy.

Midorikawa Y, Takayama T, Higaki T, Nakayama H, Yamamoto M, Ariizumi S, Shimada K, Kokudo N, Tsuji S, Tsuchiya K, Kurosaki M, Izumi N.

Jpn J Clin Oncol. 2016 Dec;46(12):1102-1107. Epub 2016 Sep 12.

PMID:
27620728
34.

RISK OF SALMONELLA IN A SUBURBAN REGION OF VIENTIANE, LAO PEOPLE’S DEMOCRATIC REPUBLIC.

Midorikawa Y, Nakamura S, Phetsouvanh R, Vongsouvaht M, Midorikawa K.

Southeast Asian J Trop Med Public Health. 2016 Sep;47(5):970-5.

PMID:
29620803
35.

Promoter hypomethylation of RAR-related orphan receptor α 1 is correlated with unfavorable clinicopathological features in patients with colorectal cancer.

Kano H, Takayama T, Midorikawa Y, Nagase H.

Biosci Trends. 2016 Jul 19;10(3):202-9. doi: 10.5582/bst.2016.01097. Epub 2016 Jun 10.

36.

Natural history of nonenhancing lesions incidentally detected during the diagnosis of hepatocellular carcinoma.

Ebisawa K, Midorikawa Y, Higaki T, Nakayama H, Tsuji S, Nishimaki H, Haradome H, Abe O, Sugitani M, Moriyama M, Takayama T.

Surgery. 2016 Sep;160(3):654-60. doi: 10.1016/j.surg.2016.04.019. Epub 2016 Jun 3.

PMID:
27267550
37.

Network-based analysis for identification of candidate genes for colorectal cancer progression.

Tsuji S, Midorikawa Y, Seki M, Takayama T, Sugiyama Y, Aburatani H.

Biochem Biophys Res Commun. 2016 Aug 5;476(4):534-540. doi: 10.1016/j.bbrc.2016.05.158. Epub 2016 May 30.

PMID:
27255996
38.

APOE Genotype in the Ethnic Majority and Minority Groups of Laos and the Implications for Non-Communicable Diseases.

Midorikawa K, Soukaloun D, Akkhavong K, Southivong B, Rattanavong O, Sengkhygnavong V, Pyaluanglath A, Sayasithsena S, Nakamura S, Midorikawa Y, Murata M.

PLoS One. 2016 May 11;11(5):e0155072. doi: 10.1371/journal.pone.0155072. eCollection 2016.

39.

Clinical score to predict the risk of bile leakage after liver resection.

Kajiwara T, Midorikawa Y, Yamazaki S, Higaki T, Nakayama H, Moriguchi M, Tsuji S, Takayama T.

BMC Surg. 2016 May 6;16(1):30. doi: 10.1186/s12893-016-0147-0.

40.

No Need of Immediate Treatment for Hypovascular Tumors Associated with Hepatocellular Carcinoma.

Midorikawa Y, Takayama T, Nara S, Hashimoto T, Omichi K, Ebisawa K, Higaki T, Tsuji S, Sakamoto H, Shimada K, Makuuchi M.

World J Surg. 2016 Oct;40(10):2460-5. doi: 10.1007/s00268-016-3548-4.

PMID:
27142625
41.

[End-of-Life Home Care for a Young Patient].

Midorikawa Y, Suzushino S, Tamotsu K, Tomizawa K, Hongou N, Usami H, Oyake M, Murakami H, Suzuki N.

Gan To Kagaku Ryoho. 2015 Dec;42 Suppl 1:60-2. Japanese.

PMID:
26809414
42.

Preoperative diagnosis with versus without MRI in resection for hepatocellular carcinoma.

Aramaki O, Takayama T, Higaki T, Nakayama H, Okubo T, Midorikawa Y, Moriguchi M.

Surgery. 2015 Dec;158(6):1512-20. doi: 10.1016/j.surg.2015.06.019. Epub 2015 Jul 20.

PMID:
26206318
43.

[Assessment of our home care and home palliative care].

Midorikawa Y, Suzushino S, Tamotsu K.

Gan To Kagaku Ryoho. 2014 Dec;41 Suppl 1:66-8. Japanese.

PMID:
25595087
44.

Photoacoustic tomography of human hepatic malignancies using intraoperative indocyanine green fluorescence imaging.

Miyata A, Ishizawa T, Kamiya M, Shimizu A, Kaneko J, Ijichi H, Shibahara J, Fukayama M, Midorikawa Y, Urano Y, Kokudo N.

PLoS One. 2014 Nov 7;9(11):e112667. doi: 10.1371/journal.pone.0112667. eCollection 2014.

45.

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.

Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, Tsuji S, Donehower LA, Slagle BL, Nakamura H, Yamamoto S, Shinbrot E, Hama N, Lehmkuhl M, Hosoda F, Arai Y, Walker K, Dahdouli M, Gotoh K, Nagae G, Gingras MC, Muzny DM, Ojima H, Shimada K, Midorikawa Y, Goss JA, Cotton R, Hayashi A, Shibahara J, Ishikawa S, Guiteau J, Tanaka M, Urushidate T, Ohashi S, Okada N, Doddapaneni H, Wang M, Zhu Y, Dinh H, Okusaka T, Kokudo N, Kosuge T, Takayama T, Fukayama M, Gibbs RA, Wheeler DA, Aburatani H, Shibata T.

Nat Genet. 2014 Dec;46(12):1267-73. doi: 10.1038/ng.3126. Epub 2014 Nov 2.

PMID:
25362482
46.

Surgical outcomes in patients with hepatocellular carcinoma associated with metabolic syndrome.

Yoshida N, Takayama T, Midorikawa Y, Higaki T, Nakayama H, Moriguchi M, Tsuji S.

World J Surg. 2015 Feb;39(2):471-7. doi: 10.1007/s00268-014-2828-0.

PMID:
25331727
47.

Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.

Takane K, Midorikawa Y, Yagi K, Sakai A, Aburatani H, Takayama T, Kaneda A.

Cancer Med. 2014 Oct;3(5):1235-45. doi: 10.1002/cam4.273. Epub 2014 May 24.

48.

[A questionnaire survey of medical cooperation by the Iwaki Medical Association].

Midorikawa Y.

Gan To Kagaku Ryoho. 2013 Dec;40 Suppl 2:202-4. Japanese.

PMID:
24712146
49.

Gastrointestinal stromal tumor with nephrotic syndrome as a paraneoplastic syndrome: a case report.

Takane K, Midorikawa Y, Yamazaki S, Kajiwara T, Yoshida N, Kusumi Y, Takayama T.

J Med Case Rep. 2014 Mar 27;8:108. doi: 10.1186/1752-1947-8-108.

50.

Decreased blood loss reduces postoperative complications in resection for hepatocellular carcinoma.

Aramaki O, Takayama T, Higaki T, Nakayama H, Ohkubo T, Midorikawa Y, Moriguchi M, Matsuyama Y.

J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):585-91. doi: 10.1002/jhbp.101. Epub 2014 Feb 19.

PMID:
24638988

Supplemental Content

Loading ...
Support Center